Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer

Joseph M. Herman, Katherine Y. Fan, Aaron T. Wild, Amy Hacker-Prietz, Laura D. Wood, Amanda L. Blackford, Susannah Ellsworth, Lei Zheng, Dung T. Le, Ana De Jesus-Acosta, Manuel Hidalgo, Ross C. Donehower, Richard D. Schulick, Barish H. Edil, Michael A. Choti, Ralph H. Hruban, Timothy M. Pawlik, John L. Cameron, Daniel A. Laheru, Christopher L. Wolfgang

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy